A device for in vitro simulation detection of implantable blood glucose sensor
By simulating the skin layer and tissue layer by bionic, combining the circulation pipeline and pumping system, the problem of inconsistent with the actual environment of the implanted blood glucose sensor is solved, the simulation and accuracy of the detection are improved, and more realistic evaluation methods are provided .
Patent Information
- Application Number
- CN202411076311.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-07
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2044-08-07
AI Technical Summary
The existing implantable blood glucose sensors have problems with batch differences and inconsistent detection environments with the actual environment, which leads to deviations in calibration values and cannot effectively simulate the stress process that penetrates the skin and dynamic changes in subcutaneous tissue.
Using bionic flexible materials to build simulated skin and tissue layers, including strength adjustable layers, hydrogel layers and circulating pipe layers, simulate skin puncture and glucose diffusion processes, and maintain test fluid flow through a pumping system to provide real dynamic response environment.
Improve the simulation and accuracy of in vitro test of implanted blood glucose sensors, broaden the scope of application of electrode detection, provide more realistic and reliable evaluation methods, ensure the closer detection environment to the actual situation, and enhance the in vitro calibration and implantation process. optimization.
Smart Images

Figure CN118604095B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of testing technology, and in particular relates to a device for in vitro simulation detection of an implantable blood glucose sensor. Background Art
[0002] Traditional blood sugar monitoring usually requires collecting blood samples from patients for measurement. This method has problems such as frequent blood sample collection, trauma, and inconvenience for long-term monitoring. In order to solve these problems, implantable blood sugar sensors came into being. By implanting the sensor under the patient's skin, the function of continuous monitoring of blood sugar levels can be achieved.
[0003] Since implantable blood glucose sensors have batch-to-batch differences during the manufacturing process, they need to be tested in vitro to calibrate the sensitivity of each sensor before leaving the factory, thereby improving the accuracy of actual in vivo measurements. Therefore, a large number of simulated in vivo tests are required during the manufacturing process of implantable blood glucose sensors. At the same time, during the research and development of implantable sensors, it is also necessary to simulate the process of sensor electrodes piercing the skin and being half-buried to determine biophysical indicators such as the strength of the electrode outer membrane and the wear resistance of the material. At present, the in vitro simulation tests of implantable blood glucose sensors are all carried out in aqueous solutions, and the electrodes are directly placed in sugar-containing solutions, which cannot effectively simulate the force process of penetrating the skin and the tissue squeezing effect of skin friction.
[0004] In addition, in the actual in vivo sensing working environment, the sugar distribution in the human tissue fluid is constantly changing. At present, the detection environment of most implantable electrodes is usually static, which is inconsistent with the flowing tissue fluid environment in the human body. This will also cause the detection environment to deviate from the actual working environment, resulting in deviations in the calibration values obtained from in vitro simulation tests. Summary of the invention
[0005] In view of the technical problem of in vitro simulation distortion of existing implantable blood glucose sensors, the purpose of the present invention is to propose a device for in vitro simulation detection of implantable blood glucose sensors, which adopts bionic flexible materials to fully simulate the process of skin puncture and the influence of subcutaneous tissue activity on electrodes, and accurately and reliably feed back the response data of sensor electrodes to different concentrations of glucose after skin puncture, so as to provide researchers with a more realistic and reliable evaluation method for the transdermal dynamic process and working stability of implantable blood glucose sensors.
[0006] To achieve the above object, the present invention adopts the following technical solution:
[0007] The present invention provides a device for in vitro simulation detection of an implantable blood glucose sensor, comprising at least:
[0008] A bionic skin layer, which is located at the top layer of the device and is used to simulate the stress state and friction of the implantable blood glucose sensor electrode during the process of puncturing the skin, and includes a strength-adjustable layer, external electric field electrodes electrically connected to both sides of the strength-adjustable layer, and a control circuit electrically connected to one end of the external electric field electrode away from the strength-adjustable layer;
[0009] A bionic tissue layer, which is located below the bionic skin layer and is used to simulate the glucose osmosis and diffusion process in tissue fluid. The bionic tissue layer includes a hydrogel layer attached below the strength-adjustable layer, a circulation pipeline layer attached to the bottom of the hydrogel layer, and a pumping system located outside the hydrogel layer, wherein a circulation pipeline is arranged on the circulation pipeline layer, and the pumping system is connected to the circulation pipeline.
[0010] In a preferred embodiment, the material of the adjustable strength layer includes electrorheological fluid material, electroactive polymer material or liquid crystal elastomer material.
[0011] In a preferred embodiment, the strength adjustment range of the adjustable strength layer is 10-50 N / cm.
[0012] In a preferred embodiment, the electrorheological fluid material includes one or more combinations of polydimethylsiloxane and graphite dopants, titanium dioxide particles and silicone oil dopants, and polystyrene particles and silicone oil dopants; the electroactive polymer material includes one or more combinations of polypyrrole-perfluorosulfonic acid ion exchange polymer mixture and polyaniline-acrylate elastomer; the liquid crystal elastomer material includes one or more combinations of acrylic-based liquid crystal elastomer, siloxane-based liquid crystal elastomer, polyurethane-liquid crystal copolymer, and styrene-based liquid crystal elastomer.
[0013] In a preferred embodiment, the thickness of the strength-adjustable layer in the bionic skin layer is between 0.5 mm and 5 mm.
[0014] In a preferred embodiment, the hydrogel layer is composed of a water-containing porous structure gel with a tensile strength of 10-30 MPa.
[0015] In a preferred embodiment, the material of the water-containing porous structure gel includes one or a combination of polyvinyl alcohol, polyacrylamide, sodium alginate, chitosan, hydroxyethyl methacrylate, hyaluronic acid, carboxymethyl cellulose, and gelatin.
[0016] In a preferred embodiment, the tube wall on the circulation pipeline in contact with the bottom surface of the hydrogel layer is configured as a semipermeable membrane structure to mimic the selective permeability function of the blood vessel wall, and the molecular weight cutoff of the tube wall is 1 KD.
[0017] In a preferred embodiment, the pumping system includes a test stock solution storage tank, a diluent storage tank, a wastewater tank and a peristaltic pump, wherein the test stock solution storage tank and the diluent storage tank are connected to one end of the circulation pipeline, and the wastewater tank is connected to the other end of the circulation pipeline.
[0018] In a preferred embodiment, the in vitro simulation detection device further comprises an analysis device, which is communicatively connected to the implantable blood glucose sensor and is used for receiving the detection data sent by the implantable blood glucose sensor in real time and performing analysis.
[0019] Compared with the prior art, the present invention has the following gain effects:
[0020] The present invention realizes the simulation degree and precision improvement of in vitro testing of implantable blood glucose sensor by constructing bionic simulated skin layer and simulated subcutaneous tissue layer. The intensity of bionic skin layer can be adjusted by electric field to simulate the skin condition of different people, and the detection application scope of implantable electrode can be broadened. The diffusion process of glucose in subcutaneous tissue can be simulated by bionic tissue layer, so that the sensor test environment and dynamic response are closer to the actual situation of human body. The test liquid channel can be formed by circulating pipeline and pumping system, so that in the process of detecting implantable blood glucose sensor, the test liquid always keeps flowing state in the pipeline, which can avoid the reduction of liquid volatilization volume during the test process and ensure the stability of the test depth of the electrode to be tested. At the same time, the simulated tissue fluid is continuously diffused outward into the hydrogel layer, and the glucose content therein is controllable and can be updated at any time, which can provide a linear diffusion change process and improve the simulation of in vitro detection. This design allows researchers and production quality inspectors to obtain more real and reliable evaluation means in the in vitro calibration, implantation process optimization experiment, dynamic test and other links of implantable blood glucose sensor. BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is a schematic diagram of the structure of a device for in vitro simulation detection of an implantable blood glucose sensor in Example 1;
[0022] Figure 2 for Figure 1 A schematic diagram of a partial structural breakdown of the device shown;
[0023] Figure 3 is a graph showing the relationship between the applied electric field voltage and the tear strength of the electrorheological fluid material in Example 2;
[0024] Figure 4 This is a concentration-time curve of the glucose penetration process in the chitosan hydrogel layer in Example 2;
[0025] Figure 5 is a graph showing the relationship between the applied electric field voltage and the tear strength of the electroactive polymer material in Example 3;
[0026] Figure 6 This is a concentration-time curve of the glucose penetration process in the polyacrylamide hydrogel layer in Example 3.
[0027] In the figure: 1. Bionic skin layer; 11. Adjustable strength layer; 12. External electric field electrode; 13. Control circuit; 2. Bionic tissue layer; 21. Hydrogel layer; 22. Circulation pipeline layer; 221. Circulation pipeline; 222. Constant pressure valve; 23. Pumping system; 51. Dilution liquid storage tank; 52. Test stock solution storage tank; 53. Wastewater tank. DETAILED DESCRIPTION
[0028] In order to make the purpose and technical solution of the present invention clearer and more complete, the present invention is further described in detail below in conjunction with the embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. Those skilled in the art can make modifications or equivalent substitutions based on the understanding of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention, which all belong to the scope of protection of the present invention.
[0029] Unless otherwise specified, the reagents and materials involved in the embodiments of the present invention are all commercially available products and can be purchased through commercial channels.
[0030] Example 1
[0031] like Figure 1 and Figure 2 As shown, this embodiment discloses a device for in vitro simulation detection of an implantable blood glucose sensor, including a bionic skin layer 1 and a bionic tissue layer 2. The bionic skin layer 1 is located at the top layer of the device, and is mainly used to simulate the stress state and friction of the implantable blood glucose sensor electrode during the skin puncture process. The bionic tissue layer 2 is located under the bionic skin layer 1, and can simulate the glucose penetration and diffusion process in the tissue fluid to achieve the purpose of regulating the glucose test concentration.
[0032] In this embodiment, the bionic skin layer 1 includes a strength-adjustable layer 11, an external electric field electrode 12 and a control circuit 13. The two sides of the strength-adjustable layer 11 are electrically connected to the external electric field electrode 12, and the control circuit 13 is electrically connected to one end of the external electric field electrode 12 on one side away from the strength-adjustable layer 11. The strength-adjustable layer 11 is composed of an electrorheological fluid material, an electroactive polymer material or a liquid crystal elastomer material, and can rapidly change the viscosity and shear modulus of the fluid under the action of an electric field, and the change process is reversible. In this way, the external electric field electrode 12 is adjusted by the control circuit 13, so that the strength-adjustable layer 11 forms simulated skin of different strengths under the action of electric fields of different sizes, so that the implantable blood glucose sensor electrode effectively simulates the stress state and friction effect during the puncture of the real skin, and ensures the simulation and accuracy of the in vitro simulation detection. Among them, the adjustment range of the skin tear strength simulated by the strength-adjustable layer 11 is 10-50 N / cm. Preferably, the electrorheological fluid material is selected from one or more combinations of polydimethylsiloxane and graphite doping, titanium dioxide particles and silicone oil doping, polystyrene particles and silicone oil doping, the electroactive polymer material is selected from one or more combinations of polypyrrole-perfluorosulfonic acid ion exchange polymer mixture, polyaniline-acrylate elastomer, and the liquid crystal elastomer material is selected from one or more combinations of acrylic liquid crystal elastomer, siloxane liquid crystal elastomer, polyurethane-liquid crystal copolymer, and styrene-based liquid crystal elastomer. It should be noted that the thickness of the adjustable strength layer 11 in the bionic skin layer 1 is set between 0.5 mm and 5 mm.
[0033] Furthermore, in this embodiment, the bionic tissue layer 2 includes a hydrogel layer 21, a circulation pipeline layer 22 and a pumping system 23. The hydrogel layer 21 is attached to the strength adjustable layer 11 and the external electric field electrode 12, and one side is partially in contact with the control circuit 13. It is composed of a water-containing porous structure gel, which is used to achieve the concentration gradient diffusion of glucose from the circulation pipeline 221 to the bionic skin layer 1. Preferably, the material of the hydrogel layer 21 is selected from one or a combination of polyvinyl alcohol, polyacrylamide, sodium alginate, chitosan, hydroxyethyl methacrylate, hyaluronic acid, carboxymethyl cellulose, and gelatin. The tensile strength of the layer can be 10-30 MPa, which is close to the tensile strength of real subcutaneous tissue, and the adjustment of the tensile strength can be achieved by regulating the cross-linking degree during the gel preparation process.
[0034] Further, the circulation pipe layer 22 is attached to the bottom of the hydrogel layer 21, and a circulation pipe 221 with a tortuous surrounding structure is arranged on it to increase the contact area between the circulation pipe 221 and the hydrogel layer 21. It should be noted that the wall of the circulation pipe 221 in contact with the hydrogel layer 21 is set as a semipermeable membrane structure, which can imitate the selective permeability function of the blood vessel wall to achieve the permeation of glucose and other test small molecules. When the glucose solution used for testing flows in the circulation pipe 221, it can diffuse to the hydrogel layer 21 through the wall of the semipermeable membrane structure. Preferably, the molecular weight retained by the wall of the semipermeable membrane structure is 1KD. In addition, a number of constant pressure valves 222 are also arranged on the circulation pipe 221. Since the test liquid in the circulation pipe 221 has the ability to diffuse and exchange to the hydrogel layer 21, the constant pressure valve 222 can ensure that the pressure at various places of the circulation pipe 221 is basically the same, so that the test liquid at various places in the circulation pipe 221 can diffuse to the hydrogel layer 21 evenly, and the accuracy of the test results is guaranteed.
[0035] Further, in this embodiment, the pumping system 23 is located outside the hydrogel layer 21 and the circulation pipeline layer 22, below the control circuit 13, and is connected to the circulation pipeline 221 in the circulation pipeline layer 22. Specifically, the pumping system 23 includes a test stock solution storage tank 52, a diluent storage tank 51, a wastewater tank 53 and a peristaltic pump, wherein the test stock solution storage tank 52 and the diluent storage tank 51 are connected to one end of the circulation pipeline 221, and the two can be mixed into a glucose solution of target concentration according to the test requirements, and the glucose solution of target concentration is pumped from one end of the circulation pipeline 221 into the circulation pipeline 221 under the action of the peristaltic pump. The wastewater tank 53 is connected to the other end of the circulation pipeline 221 to collect the waste liquid generated during the test. Under the action of the pumping system 23, the glucose solution always remains in a flowing state in the circulation pipeline 221, which can avoid the reduction of liquid evaporation volume during the test and ensure the stability of the blood glucose sensor electrode test depth. When the concentration of the glucose solution for testing needs to be updated, the pumping system 23 is used to adjust the injection ratio of the glucose stock solution in the test stock solution storage tank 52 and the water in the diluent storage tank 51 to prepare the glucose test solution of new concentration. As the glucose test solution of new concentration is pumped into the circulation pipe 221, the old test solution is discharged into the waste water tank 53 from the other end of the circulation pipe 221, thereby completing the update of the concentration of the glucose solution for testing.
[0036] Furthermore, the device for in vitro simulation detection of implantable blood glucose sensor of this embodiment also includes an analysis device. It should be understood that during the in vitro test of the implantable blood glucose sensor, the electrode of the sensor is penetrated through the strength adjustable layer 11 of the bionic skin layer 1 by the needle aid and the guide needle, and is in full contact with the hydrogel layer 21 of the bionic tissue layer 2, and the sensor detection emission module is fixed on the strength adjustable layer 11, and is connected to the analysis device for communication, and the detection data collected by the sensor electrode is sent to the analysis device in real time for analysis by researchers or quality inspectors.
[0037] Example 2
[0038] In the device for in vitro simulation detection of implantable blood glucose sensor of this embodiment, the strength adjustable layer 11 in the bionic skin layer 1 is an electrorheological fluid material composed of titanium dioxide particles and silicone oil doping, with a thickness of 2.5 mm. A voltage is applied to the external electric field electrode 12 on one side through the control circuit 13, and the applied voltage amplitude ranges from 0 V to 10 V. The corresponding relationship between the voltage amplitude and the strength of the electrorheological fluid material is as follows: Figure 3 The tear strength adjustment range of the material can effectively simulate the skin of adult males and test the puncture process of implantable blood glucose sensors on such skin.
[0039] Furthermore, in this embodiment, the bionic tissue layer 2 is located below the bionic skin layer 1, and the constituent material of the hydrogel layer 21 thereof is chitosan, and the tensile strength after chemical cross-linking is 14 MPa, which can simulate the subcutaneous tissue mainly composed of fat. The circulation pipeline layer 22 is located below the hydrogel layer 21, and a tortuous circulation pipeline 221 is arranged thereon. The diluent water and the glucose stock solution are respectively extracted from the diluent storage tank 51 and the test stock solution storage tank 52 through the pumping system 23. The two liquids are mixed in proportion according to the preset glucose solution concentration and then injected into the circulation pipeline 221. During the flow of the liquid in the circulation pipeline 221, the glucose diffuses to the hydrogel layer 21 through the tube wall of the semipermeable membrane structure under the action of the concentration gradient. The glucose concentration penetration time curve in the hydrogel layer 21 is shown in FIG. Figure 4 As shown by Figure 4 It can be seen that the data obtained in the gel simulation test of this embodiment is close to the data trend of the implanted actual measurement, and the response time is the same, while the concentration response changes dramatically in the traditional aqueous solution environment test, which is inconsistent with the actual situation in the organism. It should be noted that during the in vitro test of the implantable blood glucose sensor, the sensor electrode penetrates the strength adjustable layer 11 of the bionic skin layer 1 through the needle aid and the guide needle, and is in full contact with the hydrogel layer 21 of the bionic tissue layer 2. The sensor detection emission module is fixed on the strength adjustable layer 11, and real-time data is collected for analysis by researchers or quality inspectors.
[0040] Example 3
[0041] In the device for in vitro simulation detection of implantable blood glucose sensor of this embodiment, the strength adjustable layer 11 in the bionic skin layer 1 is an electroactive polymer material, specifically a polypyrrole-perfluorosulfonic acid ion exchange polymer mixture, with a thickness of 1.5 mm. A voltage is applied to the external electric field electrode 12 on one side through the control circuit 13, and the applied voltage amplitude ranges from 0 V to 8 V. The corresponding relationship between the voltage amplitude and the strength of the electroactive polymer material is as follows: Figure 5 The tear strength adjustment range of the material can effectively simulate children's skin and test the puncture process of implantable blood glucose sensors on such skin.
[0042] Furthermore, in this embodiment, the bionic tissue layer 2 is located below the bionic skin layer 1, and the constituent material of the hydrogel layer 21 is polyacrylamide, and the tensile strength after chemical cross-linking is 21 MPa, which can simulate subcutaneous tissue with less fat. The circulation pipeline layer 22 is located below the hydrogel layer 21, and a tortuous circulation pipeline 221 is arranged thereon. The diluent water and the glucose stock solution are respectively extracted from the diluent storage tank 51 and the test stock solution storage tank 52 through the pumping system 23. The two liquids are mixed in proportion according to the preset glucose solution concentration and then injected into the circulation pipeline 221. During the flow of the liquid in the circulation pipeline 221, the glucose diffuses to the hydrogel layer 21 through the tube wall of the semipermeable membrane structure under the action of the concentration gradient. The glucose concentration penetration time curve in the hydrogel layer 21 is shown as follows. Figure 6 As shown, it shows a gradually increasing trend, which is consistent with the actual situation in the organism. It should be noted that during the in vitro test, the implantable blood glucose sensor uses the needle aid and the guide needle to penetrate the sensor electrode through the strength adjustable layer 11 of the bionic skin layer 1 and fully contact the hydrogel layer 21 of the bionic tissue layer 2. The sensor detection and emission module is fixed on the strength adjustable layer 11 to collect data in real time for analysis by researchers or quality inspectors.
Claims
1. A device for in vitro simulation detection of an implantable blood glucose sensor, It is characterized in that At least: A bionic skin layer (1), the bionic skin layer (1) being located at the top layer of the device and used to simulate the stress state and friction of an implantable blood glucose sensor electrode during skin puncture, comprising a strength adjustable layer (11), external electric field electrodes (12) electrically connected to both sides of the strength adjustable layer (11), and a control circuit (13) electrically connected to one end of the external electric field electrode (12) away from the strength adjustable layer (11), wherein the material of the strength adjustable layer (11) comprises an electrorheological fluid material, an electroactive polymer material or a liquid crystal elastomer material, and the strength adjustment range thereof is 10-50 N / cm; A bionic tissue layer (2), the bionic tissue layer (2) being located below the bionic skin layer (1) and being used to simulate the glucose osmotic diffusion process in tissue fluid, comprising a hydrogel layer (21) attached below the strength-adjustable layer (11), a circulation pipeline layer (22) attached to the bottom of the hydrogel layer (21), and a pumping system (23) located outside the hydrogel layer (21), wherein a circulation pipeline (221) is arranged on the circulation pipeline layer (22), and the pumping system (23) is connected to the circulation pipeline (221).
2. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that The electrorheological fluid material includes one or more combinations of polydimethylsiloxane and graphite dopants, titanium dioxide particles and silicone oil dopants, and polystyrene particles and silicone oil dopants; the electroactive polymer material includes one or more combinations of polypyrrole-perfluorosulfonic acid ion exchange polymer mixture and polyaniline-acrylate elastomer; the liquid crystal elastomer material includes one or more combinations of acrylic-based liquid crystal elastomer, siloxane-based liquid crystal elastomer, polyurethane-liquid crystal copolymer, and styrene-based liquid crystal elastomer.
3. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that The thickness of the strength adjustable layer (11) in the bionic skin layer (1) is between 0.5 mm and 5 mm.
4. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that The hydrogel layer (21) is composed of a water-containing porous structure gel and has a tensile strength of 10-30 MPa.
5. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 4, It is characterized in that The material of the water-containing porous structure gel includes one or a combination of polyvinyl alcohol, polyacrylamide, sodium alginate, chitosan, hydroxyethyl methacrylate, hyaluronic acid, carboxymethyl cellulose and gelatin.
6. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that The tube wall of the circulation pipe (221) in contact with the bottom surface of the hydrogel layer (21) is configured as a semi-permeable membrane structure, which is used to imitate the selective permeability function of the blood vessel wall. The molecular weight cut-off of the tube wall is 1 KD.
7. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that The pumping system (23) comprises a test stock solution storage tank (52), a diluent storage tank (51), a waste water tank (53) and a peristaltic pump; the test stock solution storage tank (52) and the diluent storage tank (51) are connected to one end of the circulation pipeline (221), and the waste water tank (53) is connected to the other end of the circulation pipeline (221).
8. The device for in vitro simulation detection of an implantable blood glucose sensor according to claim 1, It is characterized in that It also includes an analysis device, which is communicatively connected to the implanted blood glucose sensor and is used to receive and analyze the detection data sent by the implanted blood glucose sensor in real time.
